For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It’s completely free and we guarantee you’ll learn something new every day.
While the world’s leading biotech companies â€” churning out Covid-19 vaccines and treatmentsÂ â€” have hit record share prices, their small-cap rivals have been sinking. But some analysts say the latest figures suggest a bargain in the sector.
Alone In The Red
Pfizer’s share price hit a record high for the first time in 20 years this month, topping $48, while vaccine partner BioNTech and rival vaccine producer Moderna have witnessed triple-digit gains in 2021. But all that success overshadows the struggles of other biotech stocks:
While the Nasdaq Biotech Index is up 8.7% this year, that’s mostly thanks to Moderna’s triple-digit growth. The SPDR S&P Biotech ETF, which gives equal weighting to companies (offering a more complete picture of small caps), has fallen 13%.The healthcare sector is the only sector in the red this year on the Russell 2000 Index, which tracks small-cap stocks across several industries. Small-cap healthcare stocks are down 8.7%, while utilities are up 3.8%, energy 11.9%, real estate 14.5%, financials 19%, and consumer services an impressive 25.2%.
Playing Catch-Up: Many analysts, however, think the tide could turn soon for underperforming biotechs. That’s because, historically, successes at larger biotech companies have been followed by the emergence of smaller rivals, as was the case following downturns in 2015 and 2018. “This is like being a kid in a candy store,” Federated Hermes senior portfolio manager Tom Brakel told Bloomberg News of bargain biotech stock prices.
Best Small Cap Stocks To Own Right Now: Artisan Partners Asset Management Inc.(APAM)
Artisan Partners Asset Management Inc is publicly owned investment manager. It provides its services to pension and profit sharing plans, trusts, endowments, foundations, charitable organizations, government entities, private funds and non-U.S. funds, as well as mutual funds, non-U.S. funds and collective trusts. It manages separate client-focused equity and fixed income portfolios. The firm invests in the public equity and fixed income markets across the globe. It invests in growth and value stocks of companies across all market capitalization. For fixed income component of its portfolio the firm invests in non-investment grade corporate bonds and secured and unsecured loans. It employs fundamental analysis to create its portfolios. Artisan Partners Asset Management Inc. was founded in 1994 and is based in Milwaukee, Wisconsin with additional offices in Atlanta, Georgia; New York City; San Francisco, California; Leawood, Kansas; and London, United Kingdom.